Further development led to discovery of a 4,4-difluorocyclohexylamide also known as maraviroc, which preserved excellent antiviral activity, whilst demonstrating no significant hERG binding affinity.
Maraviroc preserved excellent antiviral activity, whilst demonstrating no significant hERG binding affinity. Further development led to discovery of a 4,4-difluorocyclohexylamide also known as maraviroc.
Further development led to discovery of a 4,4-difluorocyclohexylamide also known as maraviroc. Maraviroc preserved excellent antiviral activity, whilst demonstrating no significant hERG binding affinity.
Further development led to discovery of a 4,4-difluorocyclohexylamide also known as maraviroc. Maraviroc preserved excellent antiviral activity, whilst demonstrating no significant hERG binding affinity.